查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596754

类固醇注射市场：按产品类型、给药途径、分销管道和应用划分 - 全球预测 2025-2030

Steroid Injections Market by Product Type (Cortisone, Hydrocortisone, Methylprednisolone), Administration Route (Epidural, Intra-Articular, Intramuscular), Distribution Channel, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

类固醇注射市场2023年估值为38亿美元，预计2024年将达42.9亿美元，复合年增长率为13.54%，预计到2030年将达到92.5亿美元。

类固醇注射是一种将皮质类固醇直接注射到身体发炎或疼痛部位以抑制发炎和疼痛的治疗方法。这些注射对于关节炎、肌腱炎和黏液囊炎等疾病至关重要，可以大大缓解症状并改善活动能力，对于对其他治疗没有反应的患者来说是必要的。类固醇注射用于各种医疗环境，包括医院门诊、诊所和私人诊所，最终用户范围从整形外科专家到运动医生。由于肌肉骨骼疾病的盛行率不断增加、老年人口的增加以及对微创手术的需求不断增加，类固醇注射市场正在不断增长。药物输送系统的技术进步和新型皮质类固醇的开发为市场参与者提供了利润丰厚的机会。透过策略伙伴关係和研发投资解决这些问题可以提高您的市场占有率。然而，存在一些限制，例如可能的副作用、严格的监管要求以及物理復健和口服药物等替代疗法的可用性，这些可能会阻碍市场成长。为了推动创新，公司应专注于改进可改善患者治疗效果的注射药物配方，并探索最大限度减少副作用的下一代给药技术。由于医疗基础设施的改善和先进治疗解决方案意识的提高，新兴市场提供了成长潜力，使得对这些地区的投资具有战略意义。儘管面临挑战，类固醇注射市场的性质仍然强劲，这得益于对有效疼痛管理和发炎控制疗法的持续需求。随着技术创新，对患者需求和医疗保健趋势的全面了解可以为在这个竞争激烈的市场环境中扩展和适应提供重要的机会。

主要市场统计
基准年[2023] 38亿美元
预测年份 [2024] 42.9亿美元
预测年份 [2030] 92.5亿美元
复合年增长率（%） 13.54%

市场动态：揭示快速发展的类固醇注射市场的关键市场洞察

供需的动态交互作用正在改变类固醇注射市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 整形外科疾病的发生导致老年人口增加
    • 健身运动在年轻人中越来越受欢迎
  • 市场限制因素
    • 对类固醇注射使用的严格规定
  • 市场机会
    • 整形外科手术的吸引力日益增长
    • 类固醇注射的引入和核准
  • 市场挑战
    • 与类固醇消耗相关的不良副作用

波特的五力：驾驭类固醇注射市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解类固醇注射市场的外部影响

外部宏观环境因素在塑造类固醇注射剂市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解类固醇注射市场的竞争状况

类固醇注射市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位基质类固醇注射市场供应商的绩效评估

FPNV定位矩阵是评估类固醇注射市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划类固醇注射市场的成功之路

类固醇注射市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人口增加与整形外科疾病发生
      • 健身运动深受年轻人喜爱
    • 抑制因素
      • 关于使用类固醇注射的严格规定
    • 机会
      • 人们对整容手术的兴趣日益浓厚
      • 类固醇注射的引入和核准
    • 任务
      • 与服用类固醇相关的有害副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章类固醇注射市场：依产品类型

  • 可的松
  • Hydrocortisone
  • Methylprednisolone
  • 去炎松

第七章依给药途径的类固醇注射市场

  • 硬脊膜外麻醉
  • 关节内的
  • 肌肉注射
  • 静脉

第八章类固醇注射市场：依通路分类

  • 医院药房
  • 零售药房
  • 专科诊所

第九章类固醇注射市场：依应用分类

  • 僵直性脊椎炎
  • 腰痛
  • 黏液囊炎
  • 癌症
  • 痛风
  • 骨关节炎
  • 干癣性关节炎
  • 类风湿性关节炎

第十章 北美、南美类固醇注射市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太类固醇注射市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲类固醇注射市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Actiza Pharmaceutical Private Limited
  • AdvaCare Pharma
  • ANI Pharmaceuticals, Inc.,
  • Bristol-Myers Squibb Company
  • Farmabios GmbH
  • Flagship Biotech International Private Limited.
  • Flexion Therapeutics Inc.
  • GSK plc
  • Health Biotech Limited
  • Intrapharm Laboratories
  • Merck & Co., Inc.
  • Merit Healthcare International Inc.
  • Mylan NV
  • Novartis AG
  • Perrigo Company plc
Product Code: MRR-4103B31E091F

The Steroid Injections Market was valued at USD 3.80 billion in 2023, expected to reach USD 4.29 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 9.25 billion by 2030.

Steroid injections are a medical treatment involving the administration of corticosteroids directly into inflamed or painful areas in the body to reduce inflammation and pain. Essential for conditions like arthritis, tendonitis, and bursitis, these injections provide significant relief and improve mobility, making them necessary for patients unresponsive to other treatments. Steroid injections are applied in various medical settings, including hospital outpatient departments, clinics, and private medical practices, with end-users ranging from orthopedic specialists to sports medicine practitioners. The market for steroid injections is witnessing growth driven by the increasing prevalence of musculoskeletal disorders, the rising geriatric population, and growing demand for minimally invasive procedures. Technological advancements in drug delivery systems and the development of novel corticosteroids present lucrative opportunities for market players. Addressing these through strategic partnerships and R&D investments can enhance market presence. However, the market faces limitations such as the potential for side effects, stringent regulatory requirements, and the availability of alternative therapies like physical rehabilitation and oral medications, which can hinder growth. To drive innovation, companies should focus on improving the formulation of injectable drugs for better patient outcomes and explore next-generation delivery technologies that minimize adverse effects. Markets in emerging economies offer potential growth due to increasing healthcare infrastructure and rising awareness of advanced therapeutic solutions, suggesting investment in these regions would be strategic. Despite challenges, the nature of the steroid injection market remains robust, sustained by continuous demand for effective pain management and inflammation control therapies. A comprehensive understanding of patient needs and healthcare trends, alongside technological innovation, can offer substantial opportunities for expansion and adaptation in this competitive market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 3.80 billion
Estimated Year [2024] USD 4.29 billion
Forecast Year [2030] USD 9.25 billion
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Steroid Injections Market

The Steroid Injections Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing geriatric population along with occurrences of orthopedic disorders
    • Popularity of bodybuilding among young people
  • Market Restraints
    • Stringent regulation for steroid injection usage
  • Market Opportunities
    • Growing attraction towards plastic surgeries
    • Introduction and approval of the steroid injections
  • Market Challenges
    • Harmful side effects associated with the consumption of steroids

Porter's Five Forces: A Strategic Tool for Navigating the Steroid Injections Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Steroid Injections Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Steroid Injections Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Steroid Injections Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Steroid Injections Market

A detailed market share analysis in the Steroid Injections Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Steroid Injections Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Steroid Injections Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Steroid Injections Market

A strategic analysis of the Steroid Injections Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Steroid Injections Market, highlighting leading vendors and their innovative profiles. These include Actiza Pharmaceutical Private Limited, AdvaCare Pharma, ANI Pharmaceuticals, Inc.,, Bristol-Myers Squibb Company, Farmabios GmbH, Flagship Biotech International Private Limited., Flexion Therapeutics Inc., GSK plc, Health Biotech Limited, Intrapharm Laboratories, Merck & Co., Inc., Merit Healthcare International Inc., Mylan N.V., Novartis AG, and Perrigo Company plc.

Market Segmentation & Coverage

This research report categorizes the Steroid Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cortisone, Hydrocortisone, Methylprednisolone, and Triamcinolone.
  • Based on Administration Route, market is studied across Epidural, Intra-Articular, Intramuscular, and Intravenous.
  • Based on Distribution Channel, market is studied across Hospital Pharmacy, Retail Pharmacy, and Specialty Clinics.
  • Based on Application, market is studied across Ankylosing Spondylitis, Back pain, Bursitis, Cancer, Gout, Osteoarthritis, Psoriatic Arthritis, and Rheumatoid Arthritis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing geriatric population along with occurrences of orthopedic disorders
      • 5.1.1.2. Popularity of bodybuilding among young people
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulation for steroid injection usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing attraction towards plastic surgeries
      • 5.1.3.2. Introduction and approval of the steroid injections
    • 5.1.4. Challenges
      • 5.1.4.1. Harmful side effects associated with the consumption of steroids
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Steroid Injections Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cortisone
  • 6.3. Hydrocortisone
  • 6.4. Methylprednisolone
  • 6.5. Triamcinolone

7. Steroid Injections Market, by Administration Route

  • 7.1. Introduction
  • 7.2. Epidural
  • 7.3. Intra-Articular
  • 7.4. Intramuscular
  • 7.5. Intravenous

8. Steroid Injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Retail Pharmacy
  • 8.4. Specialty Clinics

9. Steroid Injections Market, by Application

  • 9.1. Introduction
  • 9.2. Ankylosing Spondylitis
  • 9.3. Back pain
  • 9.4. Bursitis
  • 9.5. Cancer
  • 9.6. Gout
  • 9.7. Osteoarthritis
  • 9.8. Psoriatic Arthritis
  • 9.9. Rheumatoid Arthritis

10. Americas Steroid Injections Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Steroid Injections Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Steroid Injections Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Actiza Pharmaceutical Private Limited
  • 2. AdvaCare Pharma
  • 3. ANI Pharmaceuticals, Inc.,
  • 4. Bristol-Myers Squibb Company
  • 5. Farmabios GmbH
  • 6. Flagship Biotech International Private Limited.
  • 7. Flexion Therapeutics Inc.
  • 8. GSK plc
  • 9. Health Biotech Limited
  • 10. Intrapharm Laboratories
  • 11. Merck & Co., Inc.
  • 12. Merit Healthcare International Inc.
  • 13. Mylan N.V.
  • 14. Novartis AG
  • 15. Perrigo Company plc

LIST OF FIGURES

  • FIGURE 1. STEROID INJECTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. STEROID INJECTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEROID INJECTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STEROID INJECTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CORTISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 199. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023